When 89Zr-anti-CD44 was injected into HT29 tumor-bearing Balb/c nude mice with a total Ab dose of 300 μg, PET/CT images at day 4 demonstrated clearly visible HT29 tumors and showed splenic uptake that appeared lower than previous observed with low Ab dose (Fig. 6A). Here, CD44 is linked to neoplasm.